Curia Global
Americas
Albany
,
United States
Multinational
FOUNDED
1991
HEADCOUNT
1001-5000
FUNDING
Growth / PE-backed
Keywords:
CDMO, therapeutics, mammalian_cells
BUSINESS
CDMO providing integrated services from drug discovery through commercial manufacturing for small molecules, generics, sterile drug products, and biologics. Operates a global network of manufacturing facilities.
BIOTECH INVOLVEMENT
Partial; integrated CDMO covering drug discovery, small-molecule API, generics, sterile fill-finish, and biologics. The biologics arm (mammalian cell-culture mAb manufacturing) is the industrial-biotech-relevant activity within a chemistry-heavy CDMO network.
TECHNOLOGY PLATFORM
Biologics manufacturing; sterile fill-finish; small molecule synthesis
PRIMARY PRODUCTS
Contract development and manufacturing services for APIs, biologics, sterile injectables